IL-26 also directly acts on endothelial cells to induce angiogenesis, equivalent to the effect of vascular endothelial growth factor (VEGF) at inflammatory sites14, with a potential role in angiogenesis in the tumor microenvironment (TME) and malignant progression. The gene discussed is VEGFA; the disease is neoplasm.